Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy

被引:49
作者
Krause, K. [1 ]
Ardelean, E. [1 ]
Kessler, B. [1 ]
Magerl, M. [1 ]
Metz, M. [1 ]
Siebenhaar, F. [1 ]
Weller, K. [1 ]
Worm, M. [1 ]
Zuberbier, T. [1 ]
Maurer, M. [1 ]
机构
[1] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, D-10117 Berlin, Germany
关键词
anti-immunoglobulin E; mast cells; omalizumab; urticaria; urticaria factitia;
D O I
10.1111/j.1398-9995.2010.02409.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1494 / 1495
页数:2
相关论文
共 45 条
[21]   Anti-Immunoglobulin E in the Treatment of Refractory Atopic Dermatitis [J].
Amrol, David .
SOUTHERN MEDICAL JOURNAL, 2010, 103 (06) :554-558
[22]   Anti-immunoglobulin E therapy: is it a valid option for the management of chronic rhinosinusitis with nasal polyposis? [J].
Wahba, Ashraf A. ;
Abdelfattah, Ahmed M. .
EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2019, 35 (03) :269-277
[23]   Anti-immunoglobulin E therapy: is it a valid option for the management of chronic rhinosinusitis with nasal polyposis? [J].
Ashraf A. Wahba ;
Ahmed M. Abdelfattah .
The Egyptian Journal of Otolaryngology, 2019, 35 :269-277
[24]   Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection [J].
Cruz, A. A. ;
Lima, F. ;
Sarinho, E. ;
Ayre, G. ;
Martin, C. ;
Fox, H. ;
Cooper, P. J. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (02) :197-207
[25]   Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease [J].
Ao, Suiting ;
Huang, Gege ;
Tang, Xuhua ;
Zhu, Zhe ;
Han, Jiande ;
Wang, Fang ;
Zhai, Wanying .
JOURNAL OF DERMATOLOGY, 2024, 51 (04) :602-606
[26]   Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab) [J].
Milgrom, H ;
Berger, W ;
Nayak, A ;
Gupta, N ;
Pollard, S ;
McAlary, M ;
Taylor, AF ;
Rohane, P .
PEDIATRICS, 2001, 108 (02) :E36
[27]   Chronic (Cold) Contact Urticaria Treated Successfully with Anti-IgE (Omalizumab) [J].
Ozdemir, Oner .
ASTIM ALLERJI IMMUNOLOJI, 2020, 18 (01) :54-55
[28]   Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma [J].
Ayres, JG ;
Higgins, B ;
Chilvers, ER ;
Ayre, G ;
Blogg, M ;
Fox, H .
ALLERGY, 2004, 59 (07) :701-708
[29]   Management of asthma with anti-immunoglobulin E: A review of clinical trials of omalizumab [J].
Nowak, Dennis .
RESPIRATORY MEDICINE, 2006, 100 (11) :1907-1917
[30]   Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases [J].
Bousquet, J. ;
Wahn, U. ;
Meltzer, E. O. ;
Fox, H. ;
Hedgecock, S. ;
Thomas, K. ;
Fowler-Taylor, A. .
EUROPEAN RESPIRATORY REVIEW, 2008, 17 (107) :1-9